Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Brade

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2012
Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Alexander Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapySalman Faruqi, Meredith E Giuliani, Hamid Raziee, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancerAnthony Brade, Andrea Bezjak, Robert MacRae, et al.
Clinical Lung Cancer|June 17, 2015
Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New SystemHamid Raziee, Andrew Hope, Salman Faruqi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2010
Effect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patientsWinnie Li, Thomas G Purdie, Mojgan Taremi, et al.
Clinical Lung Cancer|October 26, 2017
Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT)Daniel Glick, Stephen Lyen, Sonja Kandel, et al.
Clinical Lung Cancer|December 24, 2014
Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Jennifer Y Y Kwan, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancerKatherine A Vallis, Raymond M Reilly, Deborah Scollard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasionPablo Munoz-Schuffenegger, Aisling Barry, Eshetu G Atenafu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2020
Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasionAshwathy Susan Mathew, Eshetu G Atenafu, Dawn Owen, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2012
Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Alexander Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapySalman Faruqi, Meredith E Giuliani, Hamid Raziee, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancerAnthony Brade, Andrea Bezjak, Robert MacRae, et al.
Clinical Lung Cancer|June 17, 2015
Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New SystemHamid Raziee, Andrew Hope, Salman Faruqi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2010
Effect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patientsWinnie Li, Thomas G Purdie, Mojgan Taremi, et al.
Clinical Lung Cancer|October 26, 2017
Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT)Daniel Glick, Stephen Lyen, Sonja Kandel, et al.
Clinical Lung Cancer|December 24, 2014
Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Jennifer Y Y Kwan, et al.
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancerKatherine A Vallis, Raymond M Reilly, Deborah Scollard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasionPablo Munoz-Schuffenegger, Aisling Barry, Eshetu G Atenafu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2020
Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasionAshwathy Susan Mathew, Eshetu G Atenafu, Dawn Owen, et al.
Pageof 6